A chart that illustrates how it is fundamentally impossible for China to construct a block centered around the developing world that replaces the US/ EU ...
there is an obvious problem, namely the size of China's surplus
Here is the same chart without China -- it looks totally different. That's the point.
Note one other thing: the big deficits are in India and Turkey.
2/
That is a real problem for a Sinocentric block that aims to replace the US and Europe as a source of end demand. India is absolutely not prepared to run bigger deficits with China -- and Turkey really needs to bring its deficit down.
3/
India, remember, didn't join China's trade deal (unlike say Japan ... ) and is exceptionally worried that Chinese exports are undermining its own manufacturing sector. Turkey competes with China in the EU market and isn't gonna give up the EU for China ...
4/
The bigger point of course is that the world cannot really decouple so long as there are enormous surpluses and deficits across different parts of the global economy (and different political blocks)
5/
This point is I think obvious to @michaelxpettis, me/ & others who think about "global" demand and supply imbalances. But it is not at all intuitive to the world of trade and commercial diplomacy -- and to my surprise no longer obvious to the "it's all fiscal" IMF!
@michaelxpettis ps i think the goods data tells the story more cleanly/ with fewer distortions than the broader data showing the current account (note I don't trust the Chinese current account number & current account data is more distorted by tax). But the CA numbers say the same thing
@littlebigfis and BoP based thinking is a lost art -- sadly, even at the IMF, where the norm is now "it is all fiscal" ...
• • •
Missing some Tweet in this thread? You can try to
force a refresh
US imports of pharmaceuticals from the world's low tax jurisdictions have more than tripled since the (Pharma) Tax Cuts and (Irish) Jobs Act was passed ...
1/
The US trade deficit in pharmaceuticals has gone from $50b to around $200b (close to 0.7 pp of US GDP)
I liked Trump's term one trade policy a lot better than Trump's current trade policy.
Back then, the bulk of the tariff increase was on goods from China.
Now, not so much
1/
Gearing up for the May trade data release
In April, tariff revenue was around $20b, equally split between China and the rest of the world.
During Trump's first term the increase in monthly tariff revenue (to $5/6b) was essentially from tariffs on China going from $1b to $4b
2/
Tariff revenue from countries other than China, for future reference ...
Taiwan so far has gotten off relatively lightly, largely b/c of the semiconductor exclusion from the reciprocal/ base tariffs (expected future 232 sector)
Foreign demand for US bonds was a bit too strong in 2023 and 2024; it has pushed the dollar up to untenable levels.
But there is a some risk of a real reversal now
2/
Not sure that Trump's comments over the weekend about the future path of US rates (and issuing bills until he installs a compliant Fed chair) will increase global appetite for US bonds
Just a reminder that Saudi Arabia runs a current account deficit these days -- and its break even oil price (for the balance of payments) is around $90 a barrel ...
1/
The latest balance of payments data only runs though q1 -- but the difference between the oil price and Saudi's breakeven implies a much larger deficit in q2 than in the past few quarters
2/
Saudi external asset accumulation over the last 4 quarters has been financed by debt, not out of its oil proceeds
One of the surprises of the first half of the year was that China held the yuan stable even in the face of significant new US tariffs.
China's q1 BoP data helps explain why -- China was in a quite strong underlying position
1/
in the past few quarters, China's reported current account surplus jumped up to $150b a quarter (it is still understated, I think it is really ~ $200b a quarter) and the state banks have added $50-100b a quarter to their foreign assets.
2/
The balance of payments signal from China's state bank flows (plus PBOC flows) isn't as strongly as in 2020 and 2021, but it has been pretty consistent ...
Not sure the issue will come to a head on July 9th (it is always possible to provide more time for the negotiations) but have long thought that the "232" sectors would be the hardest part of the negotiations with the EU (and other allies)
1/
Pharma frankly should be easy -- as the US trade deficit in pharmaceuticals is made in America, as it stems from a flawed US tax policy. But that isn't how the Trump administration sees it ... and the real negotiations probably cannot start before the US case.
2/
And with autos, the Trump administration's push for a quick deal with the UK set a baseline (10% tariff and tariff rate quota for 2024 export levels) that all the big auto exporters now needs to match ...
3/